Skip to content

    Recently Viewed

      Listening...

      Home / Our Company / Our societal impact / Global Health Equity /
      TB Innovation Summit 2018
      Gerry Elsdon, a TB survivor, speaking during the TB Innovation Summit in September 2018

      TB Innovation Summit 2018

      Share Article
      share to

      In the lead-up to the first-ever United Nations High-Level Meeting on Tuberculosis in September 2018, the Stop TB Partnership, Johnson & Johnson, UN Foundation, Global Fund to Fight AIDS, Tuberculosis and Malaria, and the World Economic Forum co-hosted the first of its kind TB Innovation Summit.

      The TB Innovation Summit was forward-looking, uplifting, and solutions-oriented, gathering together TB survivors and advocates, academics, civil society and community leaders, donors, and technical partners. While the task of ending TB may seem daunting, our goal is to show the world now why it is achievable if we work together in new, positive, and innovative ways.

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.